Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Neoplasms × Cisplatin × Clear all

Phase

Phase 2 13 Phase 3 4 Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 43 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 17 Head and Neck Neoplasms 14 Neoplasms 12 Stomach Neoplasms 11 Urinary Bladder Neoplasms 10 Ovarian Neoplasms 10 Esophageal Neoplasms 10 Uterine Cervical Neoplasms 9 Small Cell Lung Carcinoma 9 Pancreatic Neoplasms 9 Colorectal Neoplasms 9 Biliary Tract Neoplasms 9 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 6 Mesothelioma, Malignant 6 Melanoma 6 Carcinoma, Transitional Cell 6 Breast Neoplasms 6 Recurrence 5 Nasopharyngeal Carcinoma 5 Esophageal Squamous Cell Carcinoma 5 Cholangiocarcinoma 4 Carcinoma, Small Cell 4 Adenocarcinoma Of Esophagus 4 Radiation Injuries 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Neoplasms 3 Mesothelioma 3

Interventions

Temozolomide 23 Radiosurgery 12 Bevacizumab 11 Carboplatin 8 pembrolizumab 7 Radiotherapy 7 Trastuzumab 6 Erlotinib Hydrochloride 5 abemaciclib 4 Paclitaxel 4 Capecitabine 4 tipifarnib 3 temsirolimus 3 Sirolimus 3 Radiation 3 Irinotecan 3 Ipilimumab 3 Everolimus 3 Aminolevulinic Acid 3 tucatinib 2 pertuzumab 2 durvalumab 2 alovudine 2 Vorinostat 2 Surgical Procedures, Operative 2 Sorafenib 2 Nivolumab 2 NVP-BKM120 2 Mental Status and Dementia Tests 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡